Children and adults with Refractory acute Graft-versus-Host Disease respond to treatment with the Mesenchymal Stromal cell preparation “MSC-FFM”—Outcome report of 92 patients
- Language
-
Englisch
- Identifier
-
1216418780
Contributor
Bonig, Halvard
Kuçi, Zyrafete
Kuçi, Selim
Bakhtiar, Shahrzad
Basu, Oliver
Bug, Gesine
Dennis, Mike
Greil, Johann
Barta, Aniko
Kállay, Krisztián M.
Lang, Peter
Lucchini, Giovanna
Pol, Raj
Schulz, Ansgar
Sykora, Karl-Walter
Teichert von Luettichau, Irene
Herter-Sprie, Grit
Ashab Uddin, Mohammad
Jenkin, Phil
Alsultan, Abdulrahman
Buechner, Jochen
Stein, Jerry
Kelemen, Agnes
Jarisch, Andrea
Soerensen, Jan
Salzmann-Manrique, Emilia
Hutter, Martin
Schäfer, Richard
Seifried, Erhard
Paneesha, Shankara
Novitzky-Basso, Igor
Gefen, Aharon
Nevo, Neta
Beutel, Gernot
Schlegel, Paul-Gerhardt
Klingebiel, Thomas
Bader, Peter
Kuçi, Zyrafete
Kuçi, Selim
Bakhtiar, Shahrzad
Basu, Oliver
Bug, Gesine
Dennis, Mike
Greil, Johann
Barta, Aniko
Kállay, Krisztián M.
Lang, Peter
Lucchini, Giovanna
Pol, Raj
Schulz, Ansgar
Sykora, Karl-Walter
Teichert von Luettichau, Irene
Herter-Sprie, Grit
Ashab Uddin, Mohammad
Jenkin, Phil
Alsultan, Abdulrahman
Buechner, Jochen
Stein, Jerry
Kelemen, Agnes
Jarisch, Andrea
Soerensen, Jan
Salzmann-Manrique, Emilia
Hutter, Martin
Schäfer, Richard
Seifried, Erhard
Paneesha, Shankara
Novitzky-Basso, Igor
Gefen, Aharon
Nevo, Neta
Beutel, Gernot
Schlegel, Paul-Gerhardt
Klingebiel, Thomas
Bader, Peter
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:59 PM CET
Associated
- Bonig, Halvard
- Kuçi, Zyrafete
- Kuçi, Selim
- Bakhtiar, Shahrzad
- Basu, Oliver
- Bug, Gesine
- Dennis, Mike
- Greil, Johann
- Barta, Aniko
- Kállay, Krisztián M.
- Lang, Peter
- Lucchini, Giovanna
- Pol, Raj
- Schulz, Ansgar
- Sykora, Karl-Walter
- Teichert von Luettichau, Irene
- Herter-Sprie, Grit
- Ashab Uddin, Mohammad
- Jenkin, Phil
- Alsultan, Abdulrahman
- Buechner, Jochen
- Stein, Jerry
- Kelemen, Agnes
- Jarisch, Andrea
- Soerensen, Jan
- Salzmann-Manrique, Emilia
- Hutter, Martin
- Schäfer, Richard
- Seifried, Erhard
- Paneesha, Shankara
- Novitzky-Basso, Igor
- Gefen, Aharon
- Nevo, Neta
- Beutel, Gernot
- Schlegel, Paul-Gerhardt
- Klingebiel, Thomas
- Bader, Peter
Other Objects (12)
Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation "MSC-FFM"—outcome report of 92 patients
The phenotype and functional activity of mesenchymal stromal cells in pediatric patients with non-malignant hematological disease
Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation
Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: prognostic markers in GvHD and viral infections
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34(+)-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - a prospective international multicenter trial on behalf of the BFM‐SG and the EBMT‐PDWP
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study
Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation "MSC-FFM"—outcome report of 92 patients
The phenotype and functional activity of mesenchymal stromal cells in pediatric patients with non-malignant hematological disease
Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation
Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: prognostic markers in GvHD and viral infections
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34(+)-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - a prospective international multicenter trial on behalf of the BFM‐SG and the EBMT‐PDWP
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study
Children and adults with refractory acute graft-versus-host disease respond to treatment with the mesenchymal stromal cell preparation "MSC-FFM"—outcome report of 92 patients
The phenotype and functional activity of mesenchymal stromal cells in pediatric patients with non-malignant hematological disease
Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation
Development of three different NK cell subpopulations during immune reconstitution after pediatric allogeneic hematopoietic stem cell transplantation: prognostic markers in GvHD and viral infections
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34(+)-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
Joint modeling of immune reconstitution post haploidentical stem cell transplantation in pediatric patients with acute leukemia comparing CD34+-selected to CD3/CD19-depleted grafts in a retrospective multicenter study
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia - a prospective international multicenter trial on behalf of the BFM‐SG and the EBMT‐PDWP
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience